Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Nektar Therapeutics

Nektar Therapeutics reported $19.2M in Stock for its fiscal quarter ending in December of 2022.

Stock Change
Amgen AMGN:US USD 5.01B 81M
Biogen BIIB:US USD 1.28B 63.4M
Dr.Reddys Laboratories DRRD:IN INR 48.67B 656M
Eisai 4523:JP JPY 140.42B 19.55B
Gilead Sciences GILD:US USD 3.01B 190M
Incyte Corp INCY:US USD 40.88M 80.08M
Neurocrine Biosciences NBIX:US USD 33.4M 1.7M
Roche Holding ROG:VX 8.6B 313M
Sarepta Therapeutics SRPT:US USD 202.68M 1.29M
Seattle Genetics SGEN:US USD 477.69M 50.48M
Takeda 4502:JP JPY 986.46B 59.17B